Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (Q24245569)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks	scientific article

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (English)

0 references

atrial fibrillation

0 references

transient cerebral isolation

1 reference

based on heuristic

inferred from title

author name string

Maria I Aguilar

1

0 references

Robert Hart

2

0 references

language of work or name

0 references

publication date

19 October 2005

0 references

Cochrane Database of Systematic Reviews

0 references

4

0 references

CD001925

0 references

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Lessons from the Stroke Prevention in Atrial Fibrillation trials

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

21 January 2018

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD001925.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD001925.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24245569&oldid=1507602153"